Tau aids selection of anti-amyloid drug recipients

被引:0
|
作者
Heather Wood
机构
[1] Nature Reviews Neurology,
来源
Nature Reviews Neurology | 2024年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 63
相关论文
共 50 条
  • [1] Tau aids selection of anti-amyloid drug recipients
    Wood, Heather
    [J]. NATURE REVIEWS NEUROLOGY, 2024, 20 (02) : 63 - 63
  • [2] Candesartan-the next anti-amyloid drug?
    Yasar, Sevil
    [J]. BRAIN COMMUNICATIONS, 2022, 4 (06)
  • [3] β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population
    Rosenberg, Anna
    Ohlund-Wistbacka, Ulf
    Hall, Anette
    Bonnard, Alexandre
    Hagman, Goran
    Ryden, Marie
    Thunborg, Charlotta
    Wiggenraad, Fleur
    Sandebring-Matton, Anna
    Solomon, Alina
    Kivipelto, Miia
    [J]. NEUROLOGY, 2022, 99 (19) : E2102 - E2113
  • [4] Drosophila - a useful model for anti-amyloid drug development
    Segal, D.
    Scherzer-Attali, R.
    Peled, S.
    Shaltiel-Karyo, R.
    Frenkel-pinter, M.
    Farfara, D.
    Frenkel, D.
    Gazit, E.
    [J]. JOURNAL OF NEUROGENETICS, 2012, 26 : 15 - 16
  • [5] Anti-amyloid antibodies
    Gross, M
    [J]. CHEMISTRY IN BRITAIN, 2002, 38 (04) : 20 - 20
  • [6] Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials
    Guo, Tengfei
    Dukart, Juergen
    Brendel, Matthias
    Rominger, Axel
    Grimmer, Timo
    Yakushev, Igor
    [J]. ALZHEIMERS & DEMENTIA, 2018, 14 (11) : 1387 - 1396
  • [7] The Future of Anti-Amyloid Trials
    Aisen, P. S.
    Cummings, J.
    Doody, R.
    Kramer, L.
    Salloway, S.
    Selkoe, D. J.
    Sims, J.
    Sperling, R. A.
    Vellas, B.
    Abushakra, Susan
    Aisen, Paul
    Alam, John
    Andrieu, Sandrine
    Bansal, Anu
    Baudler, Monika
    Bell, Joanne
    Beraud, Mickael
    Bittner, Tobias
    Haeberlein, Samantha Budd
    Bullain, Szofia
    Cantillon, Marc
    Carrillo, Maria
    Castrillo-Viguera, Carmen
    Cheung, Ivan
    Coelho, Julia
    Cummings, Jeffrey
    Detke, Michael
    Di Giusto, Daniel
    Doody, Rachelle
    Dwyer, John
    Egan, Michael
    Ewen, Colin
    Fisher, Charles
    Gauthier, Serge
    Gold, Michael
    Hampel, Harald
    He, Ping
    Hendrix, Suzanne
    Henley, David
    Irizarry, Michael
    Iwata, Atsushi
    Iwatsubo, Takeshi
    Keeley, Michael
    Kerchner, Geoffrey
    Kinney, Gene
    Kolb, Hartmuth
    Kosco-Vilbois, Marie
    Kramer, Lynn
    Kurzman, Ricky
    Lannfelt, Lars
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 146 - 151
  • [8] The Future of Anti-Amyloid Trials
    P. S. Aisen
    J. Cummings
    R. Doody
    L. Kramer
    S. Salloway
    D. J. Selkoe
    J. Sims
    R. A. Sperling
    B. Vellas
    [J]. The Journal of Prevention of Alzheimer's Disease, 2020, 7 : 146 - 151
  • [9] Anti-amyloid immunotherapy for AMD
    Peter Hare
    [J]. Nature Biotechnology, 2011, 29 (9) : 809 - 809
  • [10] A novel anti-amyloid chaperone
    Johansson, J.
    Willander, H.
    Nordling, K.
    Fitzen, M.
    Nerelius, C.
    Presto, J.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 103 - 104